Skip to content

Study · Not a test of the peptide alone · 2008

1 result

Association between tumoral GH-releasing peptide receptor type 1a mRNA expression and in vivo response to GH-releasing peptide-6 in ACTH-dependent Cushing's syndrome patients.

Machado MC, Valeria de Sa S, Correa-Giannella ML, Giorgi RR, Pereira MA, Cescato VA, Giannella-Neto D, Salgado LR

European journal of endocrinology1 May 2008Cited by 11 (Europe PMC)

PMID18426818 (opens in a new tab)DOI10.1530/eje-07-0659 (opens in a new tab)PepBankPUB-18426818
Source linkPubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking GHRP-6.

  1. 01HumanNot a test of GHRP-6 aloneNon-randomized trialMechanism

    In patients with ACTH-dependent Cushing's syndrome, tumoral GHSR-1a expression was higher in patients who responded to GHRP‑6 in vivo.

    In plain wordsIn people with ACTH-dependent Cushing's syndrome, tumours had more GHSR-1a receptor in patients who responded to GHRP‑6.

    Peptide
    GHRP-6
    Outcome
    IncreaseGHSR-1a mRNA expression in patients with and without response to GHRP-6
    Study

    n = 17

    Comparator
    Patients without in vivo response to GHRP-6
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones

    Source sentences

    Summary
    GHSR-1a expression was higher in patients (CD and EAS) presenting in vivo response to GHRP-6.
    1 context sentence
    Summary · context
    Fifteen CD patients and two ectopic ACTH syndrome (EAS) patients were studied.

    In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-6.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 12:58 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:13 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.